Transcript Slide 1

Inflammation
• Inflammation is the reaction of vascularized living tissue
to injury.
• The inflammation process includes a sequence of events
that can heal the implant site.
• This is done through the generation of new tissue via its
native cells or the formation of fibroblastic scar tissue.
Some processes during inflammation
• Enhanced permeability of vasculature
• Fluid, proteins, blood cells escape vascular system into the
injured tissue
• Blood clotting --thrombosis is possible
• Cell response--neutrophils (24-48 hrs)
• Monocytes macrophages (months)
Acute vs Chronic Inflammation
• Inflammation almost always occurs.
• Distinguished not only by the time course of the
inflammatory response, but also by Cellular
interactions
• Acute inflammation, which is typical of early
phases of the inflammatory response, involves
neutrophil leukocytes as the principal cellular
effectors.
• Chronic inflammation, which tends to occur over
a longer time, involves monocytes, macrophages,
lymphocytes
The macrophage is a key cell in the
inflammation process as it can produce a
large number of biologically active products
including proteases, complement
components, coagulation factors, growth
factors and cytokines (proteins that regulate
immune response).
Biological Response
Granulation Tissue
• Granulation tissue is the fibrous connective tissue
that occurs in healing wounds. Granulation tissue
typically grows from the base of a wound and is
able to fill wounds of almost any size it heals.
• Granulation tissue is composed of tissue matrix
supporting a variety of cell types, most of which
can be associated with one of the following
functions:
– extracellular matrix,
– immune system, or
– vascularisation
Types of granulation tissue
• Extracellular matrix
– The extracellular matrix of granulation tissue is created
and modified by fibroblasts. Initially, it consists of a
network of Type III collagen, a weaker form of the
structural protein that can be produced rapidly. This is later
replaced by the stronger, long-stranded Type I collagen, as
evidenced in scar tissue.
• Immunity
– The main immune cells active in the tissue are macrophages and
neutrophils. These work to phagocytize old or damaged tissue, and
protect the healing tissue from pathogenic insult. This is necessary
both to aid the healing process and to protect against invading
pathogens, as the wound often does not have an effective skin barrier
to act as a first line of defence.
• Vascularization
– It is necessary for a network of blood vessels to be established as soon
as possible to provide the growing tissue with nutrients, to take away
cellular wastes, and transport new leukocytes to the area. Fibroblasts,
the main cells that deposit granulation tissue, depend on oxygen to
proliferate and lay down the new extracellular matrix.
Granulation tissue process
•Within 24 hrs of implantation, healing
initiated by the action of monocytes and
macrophages.
•Fibroblasts reproduce and form
granulation tissue (pink, granular
appearance)
•Neovascularization
involves
the
generation, maturation, and organization
of into capillary tubes.
•Fibroblasts are active in the synthesis of
Collagen etc.
•Granulation tissue may be observed
within 3-5 days of implantation of a
biomaterial—it is often accompanied by
wound contraction.
Foreign Body Reaction
• Indicated by the presence of multinucleated
foreign body giant cells and the components of
granulation tissue (macrophages, fibroblasts, and
capillaries)
• Surface of the biomaterial will often determine
the composition of the foreign body response
Surface structure important for
biocompatibility
• High surface to volume ratio of
fabrics and porous structures can
result in higher ratios of
macrophages than a smooth
component made of the identical
material but can also encourage
tissue ingrowth --this is observed in
vascular grafts.
Fibrosis and Encapsulation
• The final stage of the foreign body response and healing process
is the development of a fibrous encapsulation
• Repair involves two separate processes: replacement of tissue by
parenchymal cells of the same type or replacement by connective
tissue that constitute the fibrous capsule.
• These processes are controlled by the growth capacity of the
cells in the tissue receiving the implant, the persistence of the
tissue framework and degree of injury.
Host can affect the implant
• Physically
• Abrasive, adhesive,
delamination wear
• Fatigue and Fracture
• Stress Corrosion cracking
• General corrosion
• Biologically
• Absorption of substances
from the tissues
• Enzymatic degradation
• Calcification
Some Host Factors:
• Age and health status
• Immunological/metabolic
status
• Choice of surgeon:
minimize tissue damage
and contamination,
proper implantation
Implant Factors
• Bulk properties: chemical composition, structure, purity
and presence of leachables.
• Surface properties: smoothness, COF, geometry,
hyrophilicity, surface charge
• Mechanical properties: match properties of
component being replaced, such as elastic modulus.
Stability and fixation.
• Long-term structural integrity: design for fatigue and
fracture loading, wear, creep, and stress corrosion
cracking
Bioactivity spectra for bioceramics
Biocompatibility testing
•
•
•
•
•
•
•
Cell toxicity
Thromobogenecity
Inflammatory response
Animal tests
Clinical trials
FDA regulations
ASTM/ISO standards